Intrathecal morphine, but not buprenorphine or pentazocine, can induce spastic paraparesis after a noninjurious interval of spinal cord ischemia in the rat

Anesthesia and Analgesia

Volumn 99, Issue 5, 2004, Pages 1528-1531

  Nakamura, Seiya ^a   Kakinohana, Manabu ^a   Sugahara, Kazuhiro ^a   Kinjo, Sakura ^a   Miyata, Yuji ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; MORPHINE; OPIATE; PENTAZOCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA OCCLUSION; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SPECIFICITY; MALE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SPASTIC PARESIS; SPASTICITY; SPINAL CORD ISCHEMIA;

ANALGESICS, OPIOID; ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; BUPRENORPHINE; INJECTIONS, SPINAL; MALE; MORPHINE; MUSCLE WEAKNESS; PARAPARESIS; PENTAZOCINE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPINAL CORD ISCHEMIA;

EID: 6444238691     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000133915.56613.D9     Document Type: Article

References (18)

1. Crawford ES, Walter HS, Saleh SA, Normann NA. Graft replacement of aneurysm in descending thoracic aorta: results without shunting. Surgery 1981;89:73-85.
2. Crawford ES, Crawford JL, Safi HJ, et al. Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long term results of operations in 605 patients. J Vasc Surg 1986;3:389-404.
3. Kakinohana M, Marsala M, Carter C, et al. Neuraxial morphine trigger transient motor dysfunction after a noninjurious interval of spinal cord ischemia: a clinical and experimental study. Anesthesiology 2003;98:862-70.
4. Fuchigami T, Yutaka T, Kakinohana M, et al. Repetitive intrathecal administration of morphine induces irreversible paraparesis after noninjurious interval of spinal cord ischemia in the rat. Biologia (Bratisl) 1999;54:51-60.
5. Rigg JR, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 2002;359:1276-82.
6. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031-6.
7. Taira Y, Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 1996;27:1850-8.
8. Nakamura S, Kakinohana M, Taira Y, et al. The effect of gamma-aminobutyric acid (GABA) receptor drugs on morphine-induced spastic paraparesis after a noninjurious interval of spinal cord ischemia in rats. Anesth Analg 2002;95:1389-95.
9. Kakinohana M, Fuchigami T, Nakamura S, et al. Intrathecal administration of morphine, but not small dose, induced spastic paraparesis after a noninjurious interval of aortic occlusion in rats. Anesth Analg 2003;96:769-75.
10. Hoskin PJ, Hanks GW. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs 1991;41:326-44.
11. Yaksh TL. Spinal opiate: a review of their effect on spinal function with emphasis on pain processing. Acta Anaesthesiol Scand 1987;31:25-37.
12. Jankowska E, Hammar I. Spinal interneurons: how can studies in animals contribute to the understanding of spinal interneuronal systems in man? Brain Res Brain Res Rev 2002;40:19-28.
13. Yoshimura M, North RA. Substantia gelatinosa neurons in vitro hyperpolarized by enkephalin. Nature 1983;305:529-30.
14. Yaksh TL. Pharmacology and mechanisms of opioid analgesic activity. In: Yaksh TL, ed. Anesthesia: biologic foundations. Philadelphia: Lippincott-Raven Publishers, 1997:921-42.
15. Cohen GA, Doze VA, Madison DV. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 1992;9:325-35.
16. Pasternak GW, Childers SR, Snyder SH. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science 1980;208:514-6.
17. Hahn EF, Carroll-Buatti M, Pasternak GW. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. J Neurosci 1982;5:572-6.
18. Kamei J, Saitoh A, Suzuki T, et al. Buprenorphine exerts its antinociceptive activity via μ1-opioid receptors. Life Sci 1995; 56:285-90.